You have 9 free searches left this month | for more free features.

High Risk Chordoma

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Shanghai (Regional lymph node radiotherapy, chest/whole breast irradiation)

Recruiting
  • Breast Cancer
  • Regional lymph node radiotherapy
  • chest/whole breast irradiation
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Aug 3, 2023

Combined Postoperative Radiotherapy With Kidney Sparing Surgery

Recruiting
  • Locally Advanced
  • Urothelial Carcinoma Ureter
  • Radical surgery
  • Kidney sparing surgery+Postoperative radiotheray
  • Beijing, China
  • +1 more
Nov 2, 2023

Intermediate to High-risk Asymptomatic Sportsmen With Exercise

Completed
  • Electrocardiography
  • Screening stress test on a bicycle ergometer (usual practise)
  • Saint-Étienne, France
    Centre Hospitalier de Saint-Etienne
Sep 6, 2023

Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)

Not yet recruiting
  • Prostate Cancer
  • Radical Prostatectomy
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2023

Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital Southern Medical University
May 17, 2023

Patients With Ultra High Risk of Psychotic Transition Trial in Poitiers (Cerebral MRI with Phosphorus 31 Magnetic Resonance

Not yet recruiting
  • Patients With Ultra High Risk of Psychotic Transition
  • Cerebral MRI with Phosphorus 31 Magnetic Resonance Spectroscopy
  • Poitiers, France
    Centre Hospitalier Henri Laborit
May 9, 2023

High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

Recruiting
  • High-Risk Localized Soft Tissue Sarcoma
  • Pegylated Liposomal Doxorubicin
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2023

Infections, Urinary Tract, Nephrolithiasis Trial in San Francisco (Duration of antibiotics)

Not yet recruiting
  • Infections, Urinary Tract
  • Nephrolithiasis
  • Duration of antibiotics
  • San Francisco, California
    University of California, San Francisco
Nov 20, 2023

Program to Identify Participants at High Risk for Amyloid

Not yet recruiting
  • Alzheimer's Disease
  • No Intervention
  • Lady Lake, Florida
  • +1 more
Sep 12, 2023

Carotid Doppler Findings of High Risk Group of Stroke

Not yet recruiting
  • Cerebrovascular Stroke
    • (no location specified)
    Jun 23, 2023

    Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)

    Recruiting
    • Pulmonary Embolism
    • ultrasound-assisted, catheter-directed thrombolysis
    • Milano, Italia, Italy
      ASST GOM Niguarda
    Nov 21, 2023

    Hepatocellular Carcinoma Trial in Guangzhou (Atezolizumab, Bevacizumab, HAIC with FOLFOX)

    Recruiting
    • Hepatocellular Carcinoma
    • Guangzhou, Guangdong, China
      Cancer Center Sun Yat-sen University
    May 24, 2023

    Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

    Not yet recruiting
    • Colorectal Cancer
    • Liver Metastases
    • mFOLFOX6 + Cetuximab
    • mFOLFOX 6
    • Shanghai, China
      Zhongshan hosptial, Fudan University
    Jul 14, 2023

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

    Recruiting
    • Pancreatic Cancer
    • +3 more
    • Bio-specimen Collection: Blood
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 21, 2023

    Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk

    Recruiting
    • Stimulant Abuse
    • Criminal Behavior
    • Decision task
    • Albuquerque, New Mexico
      The Mind Research Network
    Apr 25, 2023

    Pressure-Volume Loop During High-Risk PCI

    Recruiting
    • Coronary Artery Disease
    • High-risk percutaneous coronary intervention
    • Detroit, Michigan
      Henry Ford Hospital
    Dec 6, 2022

    Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)

    Active, not recruiting
    • Prostate Cancer
    • High Risk
    • Houston, Texas
      Houston Methodist
    Dec 8, 2022

    Clinical Research of Drug Holiday Based on MRD Detection in GIST

    Recruiting
    • Gastrointestinal Stromal Tumors
      • Beijing, Beijing, China
        Peking University People's Hospital
      May 11, 2023

      Cardiovascular Diseases Trial in Tartu (Informing study subjects about their high CVD polygenic risk score)

      Active, not recruiting
      • Cardiovascular Diseases
      • Informing study subjects about their high CVD polygenic risk score
      • Tartu, Estonia
        Institute of Family Medicine and Public Health, University of Ta
      Oct 28, 2022

      Endotracheal Intubation Trial in Seoul (Intubation with VentiBronc Anchor endobronchial double-lumen tube, conventional

      Recruiting
      • Endotracheal Intubation
      • Intubation with VentiBronc Anchor endobronchial double-lumen tube
      • conventional double-lumen intubation
      • Seoul, Korea, Republic of
        Severance hospital
      Sep 22, 2023

      Prostate Cancer Trial in Beijing (Darolutamide+ADT)

      Not yet recruiting
      • Prostate Cancer
      • Beijing, China
        Peking University First Hospital
      Sep 1, 2023

      Hepatocellular Carcinoma Trial in Tianjin (ultrasonic testing)

      Recruiting
      • Hepatocellular Carcinoma
      • ultrasonic testing
      • Tianjin, Tianjin, China
        王芳
      Nov 20, 2023

      Based on Electronic Health RecOrds to Identify Patients at

      Not yet recruiting
      • Fabry Disease
        • (no location specified)
        Dec 20, 2022

        Preeclampsia, Perinatal Haemorrhage Trial in Guangzhou (aspirin discontinuation, aspirin continuation)

        Not yet recruiting
        • Preeclampsia
        • Perinatal Haemorrhage
        • aspirin discontinuation
        • aspirin continuation
        • Guangzhou, Guangdong, China
          FANG HE
        Oct 26, 2023

        Radiotherapy, Immunotherapy, Liver Metastases Trial in Shanghai (SBRT, Chemotherapy, PD-1 antibody)

        Recruiting
        • Radiotherapy
        • +3 more
        • SBRT
        • +2 more
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 2, 2023